Download - IN THE NAME OF GOD
![Page 1: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/1.jpg)
IN THE NAME OF
GOD
![Page 2: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/2.jpg)
Crimean–Congo Hemorrhagic Fever virus
Producer : Azam Izadi
![Page 3: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/3.jpg)
History of Crimean–Congo hemorrhagic fever
CCHF was described by a physician in the 12th century from the region that is presently Tadzhikistan.
Hemorrhagic disease with the presence of blood in:
o Urineo Vomituso Gumso Sputumo Abdominal cavity
Caused by a tick
![Page 4: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/4.jpg)
CCHF had three names in southern Uzbekistan:
• khungribta (blood taking)• Khunymuny (nose bleeding)• karakhalak (black death)
![Page 5: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/5.jpg)
Discovery of virus: CHF came to the attention of modern
medical science in 1944–1945 when about 200 Soviet military personnel were infected during an epidemic in war-torn Crimea.
Virus isolated from a patient in Congo in 1956
![Page 6: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/6.jpg)
This now gave researchers an actual virus for production of the necessary reagents needed for serological surveys.
In 1967a breakthrough in CHF research came when Chumakov at the Institute of Poliomyelitis in Moscow first used newborn white mice for CHF virus isolation.
![Page 7: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/7.jpg)
Classification of virus:
CCHFV is a member of the Nairovirus genus of the family Bunyaviridae.
There are seven recognized species in the genus Nairovirus containing 34 viral strains
![Page 8: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/8.jpg)
Structure of virus:
Virions are spherical
Helical nucleocapsid
Approximately 100 nm in diameter
Lipid bilayered envelope approximately 5–7 nm thickGlycoprotein spikes 8–10 nm in length
![Page 9: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/9.jpg)
Contain three structural proteins:
Two envelope glycoproteins G2 and G1
Nucleocapsid protein (N)
![Page 10: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/10.jpg)
Genome of virus
The genome is composed of three negative-strand RNA segments:S, M, and L.(11-19 kb)
S encoding N nucleocapsid M encoding G2 and G1 glycoproteins L encoding L polymerase
![Page 11: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/11.jpg)
![Page 12: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/12.jpg)
The three RNA genome segments (S, M, and L) are complexed with nucleocapsid protein to form ribonucleocapsid structures.
The nucleocapsids and RNA dependent RNA polymerase are packaged within a lipid envelope that contains the viral glycoproteins G1 and G2.
![Page 13: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/13.jpg)
1. attachment of virions to cell-surface receptors
2. entry via endocytosis followed by membrane fusion
3. primary transcription ( Transcription of negative sense vRNA to mRNA)
4. translation of viral proteins
Replication of virus:
![Page 14: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/14.jpg)
Translation :
L and S segments of mRNA are translated on free ribosomes in cytoplasm
M segment mRNA is translated on ER-bound ribosomes
![Page 15: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/15.jpg)
5. replication of vRNA via a cRNA intermediate
vRNA is used as a template by viral polymerase to make cRNA
cRNA is used as a template to make more negative sense strands of vRNA
![Page 16: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/16.jpg)
6. assembly of virions at the Golgi or plasma membrane
7. egress by budding into the
Golgi followed by exocytosis, or budding through the plasma membrane.
![Page 17: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/17.jpg)
Replication cycle
![Page 18: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/18.jpg)
Tick vectors:
CCHFV has been isolated from at least 31 species of ticks.
The biological role of ticks is also important, not only as virus vectors, but also as reservoirs of the virus in nature.
Hyalomma anatolicum ticks a common CCHFV vector .
![Page 19: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/19.jpg)
Vertebrate reservoir hosts:
Isolated from numerous domestic and wild vertebrates, including:
-Goats-Sheep-Hares-Mouse-Domestic dogs-Horses-Donkeys
![Page 20: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/20.jpg)
After experimental inoculation of birds with CCHFV, they remained healthy.
Birds appear to be refractory to CCHF viremia.
In 1984, a case of CCHF occurred in a worker who became ill after slaughtering ostriches on a farm in South Africa.
![Page 21: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/21.jpg)
tick–vertebrate–tick cycle
![Page 22: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/22.jpg)
How is the disease transmitted to humans?
- Congo fever is transmissible to humans through contact with infected blood, other tissue or a tick bite.
-People handling livestock or ostriches
during routine procedures, such as vaccinations or
slaughtering of animals, are at risk.
-People can also get infected through the handling of ticks.
![Page 23: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/23.jpg)
Four distinct phases: 1- Incubation:the incubation period after a tick
bite can be as short as 1–3 days, but can much longer.
2- Prehemorrhagic:
Sudden fever(39-41 ◦C) , 5-12 days
Chills
Headache
Dizziness
Photophobia
Abdominal pains, vomiting, diarrhea
Brady cardia, low blood pressure
.
![Page 24: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/24.jpg)
3-Hemorrhagic: In severe cases, 3–6 days after onset of disease:
The virus attacks and destroys blood vessels.
The red rash, first appears on the whites of the eyes, roof of the mouth, throat and skin. this rash spreads and bleeding from the bowel.
Petechiae and ecchymosis
![Page 25: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/25.jpg)
Bleeding from: Nose Gums Vagina Blood in the urine
Vomitus and tar-like stools resulting from intestinal hemorrhages.
In severe cases, the haemorrhaging causes major organs - such as the liver, kidneys and lungs - to fail.
![Page 26: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/26.jpg)
4-Convalescence: it begins about 15–20 days after onset of illness
Weak pulse
Sometimes complete loss of hair
Headache, dizziness, nausea
Poor appetite, poor vision
Loss of hearing, and loss of memory
These problems are rarely permanent,
but may persist for a year or more.
![Page 27: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/27.jpg)
Fever
Headache
Sore throat
General malaise
Muscle aches
Sore eyes, including light sensitivity. Red rash on the eyes, roof of the mouth and skin, caused by haemorrhaging of tiny blood vessels.
Symptoms:
![Page 28: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/28.jpg)
Nosebleeding
Bleeding gums
Nausea
Loss of appetite
Vomiting
Diarrhoea
Chest painDizzinessSeizuresDeath
![Page 29: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/29.jpg)
Antibody Response in CCHF:
IgG and IgM antibodies became demonstrable by indirect immunofluorescence on days 7 to 9 of illness
Maximum titers of antibody were usually attained in the second to third week of illness.
Titers of IgM declined gradually and were low or negative by the fourth month. .
![Page 30: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/30.jpg)
In some patients titers of IgG increased markedly between 2 and 4 months after onset of illness and remained demonstrable by indirect immunofluorescence 3 years after infection.
Techniques for demonstrating antibody were: indirect immunofluorescencecomplement-fixation immunodiffusion
![Page 31: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/31.jpg)
Viral detection : (blood specimen)
-RT-PCR
- Cell culture
Antibody detection : (serum sample)- IFA - ELISA
CCHF : laboratory diagnosisCCHF : laboratory diagnosis
![Page 32: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/32.jpg)
VACCINE:An inactivated suckling mouse brain vaccine was developed in the Soviet Union in 1960.
Brain tissue suspensions were inactivated by formaldehyde and heat treatment to obtain safe.
The efficacy of the vaccine was tested using the complement fixation (CF) technique.
![Page 33: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/33.jpg)
.
Modern vaccines are DNA vaccines, recombinant viral protein-based vaccines.
American scientists have developed a DNA vaccine containing the CCHFV genome M segment.
The vaccine has been used for high risk groups in Bulgaria since 1974. There are concerns about using mouse brain vaccine because of possible autoimmune responses.
![Page 34: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/34.jpg)
How can people at risk be protected against CCHF?Many human infections result by tick bites:
- Animals should be treated with acaricides to reduce the number of ticks.
- Clothing can be treated with acaricides.
People coming into contact with fresh blood are at risk:
- Protective clothing should be worn
![Page 35: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/35.jpg)
Prevention strategiesAvoid travelling to regions where CCHF is endemic.
Wear long trousers, long socks and boots when outdoors.Use insect repellent on all areas of exposed skin.
Avoid touching animals or, if you must, wear gloves and other protective clothing.
If you find a tick on your skin, Use tweezers to grasp the tick’s head, then pull the tick out of your skin, don’t squeeze the tick’s body.
![Page 36: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/36.jpg)
TREATMENT: Ribavirin: The efficacy of ribavirin against
CCHFV was first described in vitro in 1989.
Ribavirin is a purine nucleoside analogue with broad-spectrum antiviral activity.
![Page 37: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/37.jpg)
A recent study confirmed that ribavirin inhibited CCHFV replication .
In a study in suckling mice using the ribavirin significantly reduced viral replication in the liver and prevented infection of brain and heart tissues.
![Page 38: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/38.jpg)
WITH RIBAVIRIN:
Higher survival rates
Shorter recovery time
Earlier return to normal levels of laboratory parameters
![Page 39: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/39.jpg)
CCHFV possesses mechanisms to defeat the interferon-induced defense mechanisms by delaying IFN secretion for 48 hours post-infection.
Recombinant interferons exhibit activity against CCHFV in vitro
![Page 40: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/40.jpg)
Mortality rate:
-The average mortality rate is 30–50%
-However, rates as high as 72.7% and 80% have been reported from the United Arab Emirates and China.
![Page 41: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/41.jpg)
CCHFV might be used as an agent of bioterrorism or biowarfare.
CCHFV can be transmitted from person to person, has a high case-fatality rate.
BIOTERORISM:
![Page 42: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/42.jpg)
Geographical distributionThere are reports of viral isolation and disease from more than 30 countries in Africa, Asia, southeast Europe.
![Page 43: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/43.jpg)
Turkey has experienced the largest ever recorded CCHF outbreak with more than 4,400 confirmed cases mainly from rural areas.
![Page 44: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/44.jpg)
CCHF in IRAN:610 cases have been reported in Zahedan 100 cases have been reported in Khorasan
![Page 45: IN THE NAME OF GOD](https://reader036.vdocument.in/reader036/viewer/2022062410/5681532b550346895dc15081/html5/thumbnails/45.jpg)
References1-Whitehouse ,C.,(2004), Crimean–Congo hemorrhagic fever,Crimean–Congo fever, Antiviral Research,64:145-160
2- Paragas,J. Whitehouse,C. Endy,T. Bray,M.,(2004),A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus, Antiviral Research,62:21-25
3-Samudzia,R. Lemanb, P. Paweskab,J. Swanepoelb,R. Burta,F.,(2012), Bacterial expression of Crimean-Congo hemorrhagic fever virus nucleoprotein, Journal of Virological Methods ,179:70-76
4-Shepherd,J.Swanepoel,R.Leman,A., (1989), Antibody Response in Crimean-Congo Hemorrhagic Fever, Clin Infect Dis,11:801-806
5- Keshtkar,M. ,Kuhnb,J. Christovac,I. Bradfuted,B.,(2011), Crimean-Congo hemorrhagic fever: Current and future prospects of vaccines and therapies, Antiviral Research ,90:85-92